Skip to content
← Full study record

NCT00153920 · MORE INFO

Limitations, agreements, and source contact

Bortezomib (Velcade) in Patients With Untreated Multiple Myeloma · Source last updated 2019-06-11

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
point Of Contact
email
Paul_Richardson@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617.632.2104
title
Paul G. Richardson
Complete source fields
certain Agreement
pi Sponsor Employee
true
restrictive Agreement
false
point Of Contact
email
Paul_Richardson@dfci.harvard.edu
organization
Dana-Farber Cancer Institute
phone
617.632.2104
title
Paul G. Richardson

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice